Shijiazhuang No.4 Pharmaceutical Co., Ltd. entered into an agreement to acquire 6.1% stake in Cisen Pharmaceutical Co., Ltd. (SHSE:603367) from Wu Hengke for approximately CNY 350 million on July 29, 2021. Under the terms of transaction, Shijiazhuang will purchase 27.661 million shares at purchase price of CNY 12.8 per share. The consideration for the Acquisition will be funded mainly by the internal resources of the Group.